Lisa Porter
Technik-/Wissenschafts-/F&E-Leiter bei VIVANI MEDICAL, INC.
Vermögen: - $ am 30.04.2024
Profil
Lisa E.
Porter is currently the Director at ViaCyte, Inc. and the Chief Medical Officer at Vivani Medical, Inc. Her former jobs include being the Group Director-Metabolism at GSK Plc from 1999 to 2004, Associate Medical Director at Zeneca Pharmaceuticals from 1997 to 1999, Vice President-Medical Development at Amylin Pharmaceuticals, Inc. from 2004 to 2013, Chief Medical Officer at Nano Precision Medical, Inc., Chief Medical Officer at Aerami Therapeutics, Inc. from 2014 to 2017, and Chief Medical Officer at Eiger BioPharmaceuticals, Inc. She received her undergraduate degree from The College of William & Mary and her doctorate from Duke University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VIVANI MEDICAL INC.
-.--% | 10.05.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Lisa Porter
| Unternehmen | Position | Beginn |
|---|---|---|
| VIVANI MEDICAL, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.08.2022 |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 19.01.2022 |
Ehemalige bekannte Positionen von Lisa Porter
| Unternehmen | Position | Ende |
|---|---|---|
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.01.2013 |
| GSK PLC | Corporate Officer/Principal | 01.01.2004 |
Zeneca Pharmaceuticals
 Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Corporate Officer/Principal | - |
Nano Precision Medical, Inc.
 Nano Precision Medical, Inc. Medical SpecialtiesHealth Technology Nano Precision Medical, Inc. provides pharmaceutical services. The firm specializes in nanotechnology, materials, drug delivery and formulation. The company was founded by Kathleen Fischer, Aaron Mendelsohn, Adam Mendelsohn and Lily Peng in 2009 and is headquartered in Emeryville, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Lisa Porter
| The College of William & Mary | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GSK PLC | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| VIVANI MEDICAL, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Health Technology |
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
Nano Precision Medical, Inc.
Nano Precision Medical, Inc. Medical SpecialtiesHealth Technology Nano Precision Medical, Inc. provides pharmaceutical services. The firm specializes in nanotechnology, materials, drug delivery and formulation. The company was founded by Kathleen Fischer, Aaron Mendelsohn, Adam Mendelsohn and Lily Peng in 2009 and is headquartered in Emeryville, CA. | Health Technology |
